Women in IBD: Outstanding Researcher Award Nomination Form

Nomination deadline: Tuesday, June 30, 2020 at 5 p.m. ET

Prize amount: $25,000 (For investment in the recipient’s research program) 
The recipient of this award will have their travel, accommodation and conference fees paid to attend the Meeting of the Minds conference in Toronto on November 6 and 7, 2020. They will be recognized at the Meeting of the Minds conference and have an opportunity to present their work.

Award description: This award recognizes an exceptional female basic or clinical researcher who has been an inspirational leader and role model in the field of IBD research, and contributed significantly to advancing the mission of Crohn’s and Colitis Canada.

Recipients of the Outstanding Researcher Award are innovative and productive leaders advancing IBD research and/or quality of patient care in Canada.

Eligibility:

  • Female IBD basic or clinical researchers in Canada
  • Nominee must be affiliated with an academic institution in Canada 

How to apply:

  • Complete the nomination form
  • Attach a letter of support from the nominating applicant, the nominee’s department head, or an IBD colleague
  • Attach a CV highlighting the nominee’s accomplishments as it pertains to this award

Nomination criteria: Self-nominations and nominations by IBD colleagues will be accepted. 
 
Selection criteria: Nominations will be evaluated for demonstrated innovation and leadership in the field of IBD research in Canada as well as commitment to the mission of Crohn’s and Colitis Canada. The recipient will be selected by a Selection Panel comprised of individuals from the following groups, at the discretion of Crohn’s and Colitis Canada, and as appropriate:

  • Crohn’s and Colitis Canada Scientific and Medical Advisory Council;
  • Canadian Community of Practice of IBD Nurses (CANIBD) members;
  • Crohn’s and Colitis Canada IBD patient volunteers;
  • Crohn’s and Colitis Canada staff; or
  • Other individuals as deemed necessary by Crohn’s and Colitis Canada

Evaluation guidelines (Based on applicant responses, letter of support, and nominee CV):

  • Evidence of positively impacting the IBD community and/or patient care in Canada
  • Evidence of leadership role(s) impacting IBD research, quality of care, and/or policies in Canada
  • Contribution to the mission and values of Crohn’s and Colitis Canada
  • Quality of recommendation from letter of support

For any questions regarding this award or the application process, please contact Katy Devitt, Manager, Research Programs at kdevitt@crohnsandcolitis.ca or 416-920-5035 x229.

Nomination Form

The name of the individual you are nominating
Your name
Max 250 words
Max 250 words
Files must be below 10 MB in size
Files must be below 10 MB in size
 Security code

 

Sponsored by

pfizer_cmyk_pos.png
 
Crohn's and Colitis Canada logo

  • Canada has among the highest incidence rates of Crohn's and colitis in the world.
  • 1 in 140 Canadians lives with Crohn’s or colitis.
  • Families new to Canada are developing these diseases for the first time.
  • Incidence of Crohn’s in Canadian kids under 10 has doubled since 1995.
  • People are most commonly diagnosed before age 30.

Other Areas of Interest